Who backs Parabilis Medicines?
38 investors| Investor | Type |
|---|---|
| General Catalyst | Venture capital |
| Fidelity Management & Research Company | Asset manager |
| RA Capital Management | Asset manager |
| GV | Venture capital |
| ARCH Venture Partners | Venture capital |
| Catalio Capital Management | Venture capital |
| T. Rowe Price Group | — |
| Horizons Ventures | Venture capital |
| The Invus Group | PE / buyout |
| Foresite Capital | Venture capital |
| + 28 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 38 names
- ·Watchlist + deal alerts for Parabilis Medicines
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 38 firms already write checks for companies like Parabilis Medicines in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.